Literature DB >> 29860868

Early Life HIV-1 Immunization: Providing a Window for Protection Before Sexual Debut.

Sallie Permar1,2, Ofer Levy3,4,5, Tobias R Kollman6, Anjali Singh7, Kristina De Paris8.   

Abstract

Limited success of current HIV-1 vaccines warrants new approaches. We discuss feasibility and potential benefits of early life HIV-1 immunization followed by vaccine boosts during childhood that may enable maturation of vaccine-induced broad anti-HIV-1 immunity over several years. By initiating this immunization approach in the very young, well before sexual debut, such a strategy may dramatically reduce the risk of HIV-1 infection.

Entities:  

Keywords:  HIV prevention; immune development; vaccine

Mesh：

Substances：

Year:  2018        PMID： 29860868      PMCID： PMC6204561          DOI： 10.1089/AID.2018.0018

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN： 0889-2229            Impact factor:   2.205


  42 in total

1.  Immunology, one cell at a time.

Authors:  Amir Giladi; Ido Amit
Journal:  Nature       Date:  2017-07-03       Impact factor: 49.962

Review 2.  Protecting the Newborn and Young Infant from Infectious Diseases: Lessons from Immune Ontogeny.

Authors:  Tobias R Kollmann; Beate Kampmann; Sarkis K Mazmanian; Arnaud Marchant; Ofer Levy
Journal:  Immunity       Date:  2017-03-21       Impact factor: 31.745

3.  Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection.

Authors:  K K Van Rompay; C J Berardi; S Dillard-Telm; R P Tarara; D R Canfield; C R Valverde; D C Montefiori; K S Cole; R C Montelaro; C J Miller; M L Marthas
Journal:  J Infect Dis       Date:  1998-05       Impact factor: 5.226

Review 4.  Systems serology for evaluation of HIV vaccine trials.

Authors:  Margaret E Ackerman; Dan H Barouch; Galit Alter
Journal:  Immunol Rev       Date:  2017-01       Impact factor: 12.988

5.  Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV.

Authors:  Koen K A Van Rompay; Kristina Abel; Jonathan R Lawson; Raman P Singh; Kimberli A Schmidt; Thomas Evans; Patricia Earl; Danielle Harvey; Genoveffa Franchini; James Tartaglia; David Montefiori; Shilpa Hattangadi; Bernard Moss; Marta L Marthas
Journal:  J Acquir Immune Defic Syndr       Date:  2005-02-01       Impact factor: 3.731

6.  Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848.

Authors:  Ofer Levy; Kol A Zarember; Rene M Roy; Colette Cywes; Paul J Godowski; Michael R Wessels
Journal:  J Immunol       Date:  2004-10-01       Impact factor: 5.422

7.  HIV-1 Neutralizing Antibodies with Limited Hypermutation from an Infant.

Authors:  Cassandra A Simonich; Katherine L Williams; Hans P Verkerke; James A Williams; Ruth Nduati; Kelly K Lee; Julie Overbaugh
Journal:  Cell       Date:  2016-06-23       Impact factor: 41.582

8.  Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines.

Authors:  Amy W Chung; Musie Ghebremichael; Hannah Robinson; Eric Brown; Ickwon Choi; Sophie Lane; Anne-Sophie Dugast; Matthew K Schoen; Morgane Rolland; Todd J Suscovich; Alison E Mahan; Larry Liao; Hendrik Streeck; Charla Andrews; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Mark S de Souza; Jaranit Kaewkungwal; Punnee Pitisuttithum; Donald Francis; Nelson L Michael; Jerome H Kim; Chris Bailey-Kellogg; Margaret E Ackerman; Galit Alter
Journal:  Sci Transl Med       Date:  2014-03-19       Impact factor: 17.956

9.  Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses.

Authors:  Genevieve G Fouda; Coleen K Cunningham; Elizabeth J McFarland; William Borkowsky; Petronella Muresan; Justin Pollara; Lin Ye Song; Brooke E Liebl; Kaylan Whitaker; Xiaoying Shen; Nathan A Vandergrift; R Glenn Overman; Nicole L Yates; M Anthony Moody; Carrie Fry; Jerome H Kim; Nelson L Michael; Merlin Robb; Punnee Pitisuttithum; Jaranit Kaewkungwal; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Hua-Xin Liao; Barton F Haynes; David C Montefiori; Guido Ferrari; Georgia D Tomaras; Sallie R Permar
Journal:  J Infect Dis       Date:  2014-08-27       Impact factor: 7.759

10.  Circulating Human Neonatal Naïve B Cells are Deficient in CD73 Impairing Purine Salvage.

Authors:  Matthew Aaron Pettengill; Ofer Levy
Journal:  Front Immunol       Date:  2016-03-30       Impact factor: 7.561
View more
  3 in total

Review 1.  Immunization: vital progress, unfinished agenda.

Authors:  Peter Piot; Heidi J Larson; Katherine L O'Brien; John N'kengasong; Edmond Ng; Samba Sow; Beate Kampmann
Journal:  Nature       Date:  2019-11-06       Impact factor: 49.962

2.  AIDS Vaccine Research Subcommittee (AVRS) Consultation: Early-Life Immunization Strategies against HIV Acquisition.

Authors:  Anjali Singh; Sallie Permar; Tobias R Kollmann; Ofer Levy; Mary Marovich; Kristina De Paris
Journal:  mSphere       Date:  2019-07-17       Impact factor: 4.389

3.  Bringing the path toward an HIV-1 vaccine into focus.

Authors:  Cesar J Lopez Angel; Georgia D Tomaras
Journal:  PLoS Pathog       Date:  2020-09-10       Impact factor: 6.823
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.